Development of second primary malignancies after transoral surgery in human papilloma virus-positive oropharyngeal squamous cell carcinoma

Katelyn Stepan, Ethan Craig, Scott Andrew Skillington, Brian C. Deutsch, Stephanie Chen, Nneoma S. Wamkpah, Craig A. Bollig, Dorina Kallogjeri, Wade L. Thorstad, Sidharth V. Puram, Patrik Pipkorn, Ryan S. Jackson

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Little data exists regarding the incidence of oropharyngeal and upper aerodigestive tract (UADT) second primary malignancies (SPM) among human papilloma virus (HPV)-positive oropharyngeal squamous cell carcinoma (OPSCC). Here we evaluate SPM rates among patients with HPV-related OPSCC. Methods: A retrospective cohort study of 412 patients with HPV-related OPSCC who underwent transoral resection +/− adjuvant therapy at a single center between 1996 and 2018. Results: Twenty patients (4.9%) developed SPM of the UADT, nine (2.2%) occurring in the oropharynx. Median time to diagnosis was 59.5 months (0–173 months). Risk of SPM was lower for patients receiving adjuvant radiation (aHR: 0.25, 95%CI: 0.08–0.78). There was no difference in overall or disease-free survival between those with and without SPM. Conclusion: The rate of SPM among patients with HPV-positive OPSCC is lower than reported rates among HPV-negative OPSCC. To date, this is the largest study evaluating SPM in patients with surgically treated HPV-positive OPSCC.

Original languageEnglish
Pages (from-to)1069-1078
Number of pages10
JournalHead and Neck
Volume44
Issue number5
DOIs
StatePublished - May 2022

Keywords

  • HPV
  • oropharynx
  • second primary
  • squamous cell carcinoma
  • transoral surgery

Fingerprint

Dive into the research topics of 'Development of second primary malignancies after transoral surgery in human papilloma virus-positive oropharyngeal squamous cell carcinoma'. Together they form a unique fingerprint.

Cite this